Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Efinaconazole

A topical triazole antifungal discovered in Japan and approved in the United States in 2014 for onychomycosis of the toenails, a fungal nail infection; it was later approved in Japan and South Korea as well. This family brings together the active ingredient, metabolites, labelled standards and other impurities.

Did you know?It binds only weakly to keratin, the protein nails are made of: so it is not held back at the surface and can pass through the nail plate to reach the fungus.

EfinaconazoleGo to the active ingredient →
EfinaconazoleActive ingredientEfinaconazoleCat. No. P-E013-001CAS 164650-44-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.